Organon & Co.
4.45 %
-41.88 %
Yet to be announced
Company Overview
Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies.
Revenue Sources
PassBased on review of Organon's product portfolio and revenue sources, their primary income streams come from pharmaceutical products and medical treatments. While some of their products include contraceptives, these are considered permissible from an Islamic perspective when used within marriage. The company does not derive significant revenue from explicitly haram sources.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2024 | $1.59b | $1.46b | - | $153.0m | 0.00% | 10.50% |
| Sept. 30, 2024 | $1.58b | $1.37b | - | $126.0m | 0.00% | 9.20% |
| June 30, 2024 | $1.61b | $1.37b | - | $131.0m | 0.00% | 9.58% |
| March 31, 2024 | $1.62b | $1.38b | - | $131.0m | 0.00% | 9.51% |
Analysis of the last four quarters shows interest expenses represent a material portion of total expenses. Interest expense has consistently been around $126-131 million per quarter, while total expenses range from $1.37-1.49 billion. The ratio of interest expense to total expenses exceeds 5% across all quarters analyzed, indicating interest plays a material role in the company's operations.
Operational Ethics
PassBased on available information from SEC filings and company reports, there is no evidence of current material associations with entities involved in human rights violations such as the state of Israel or the Chinese Communist Party.
Comments